| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |